The global enteral nutrition market is expected to reach USD 11,726. US$7,803 to 37 million by 2028. 45 million in 2021. It is expected to grow at a CAGR of 6.0% from 2022 to 2028.
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — Reportlinker.com presents the report, Enteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Indications, by Nutrition Type, Form, Product and Distribution. Announcing the release of the Global Analysis ofchannel, age group [Child and Adults ]” – https://www.reportlinker.com/p06321036/?utm_source=GNW
Enteral nutrition (EN) is offered to patients who cannot meet their energy and nutritional needs with normal food intake. The advantages of enteral feeding over parenteral nutrition are well recognized.
For most pediatric patients dependent on enteral nutrition, a fiber-rich, age-appropriate standard polymer formula is a good choice.
Crohn’s disease, digestive disorders due to trauma, intestinal obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are some of the digestive disorders.According to an article in Heathline, by 2021 people around the world will Approximately 40% of patients are affected by functional gastrointestinal disorders.
In developed countries, intra-abdominal adhesions are the most common cause of small bowel obstruction (SBO), accounting for approximately 65-75% of cases, followed by hernias, according to Medscape. In contrast, in developing countries, SBO is mainly caused by hernia (30-40%), adhesions (~30%), and tuberculosis (~10%).
According to an article published by the World Journal of Emergency Surgery, intestinal obstruction is a significant cause of morbidity and mortality, causing nearly 30,000 deaths and more than US$3 billion in direct medical costs annually. In the United States, approximately 15% of hospitalizations for acute abdominal pain are due to intestinal obstruction, and approximately 20% of cases require acute surgical intervention.
Crohn’s disease is a complex, long-term (chronic) disease that primarily affects the digestive system. It is the most common disease in North America and Western Europe, with a prevalence of 100 to 300 per 100,000 people in these regions.
More than 500,000 people in North America and Western Europe currently suffer from Crohn’s disease, according to Medline Plus. Anorexia due to anorexia, or altered nutritional requirements caused by the disease itself.
Enteral medical nutrition is preferred because patients with gastrointestinal disease cannot take food orally. Hence, the rising prevalence of gastrointestinal diseases across the globe is driving the growth of the enteral medical nutrition market.
Based on indication, the enteral medical nutrition market is segmented on the basis of respiratory disease, cancer, post-COVID-19, gastrointestinal disease, liver failure, and others. The respiratory disease segment market is further segmented into chronic obstructive pulmonary disease. respiratory failure, cystic fibrosis, etc.
In 2021, the respiratory disease segment held the largest share of the market. Increasing prevalence of respiratory diseases is driving the market growth of this segment.
According to the National Hospital Ambulatory Medical Care Survey: 2018, there were 873,000 emergency department visits for COPD in the United States. The cancer segment market is sub-segmented into cancer cachexia, cachexia with COPD, and others.
Cancer segment is expected to register the highest CAGR during 2022-2028. The enteral medical nutrition market for gastrointestinal disorders segment is further segmented into intestinal obstruction, Crohn’s disease, short bowel syndrome and others.
Based on nutrition type, the enteral medical nutrition market is divided into supplements and sole sources.In 2021, the supplement segment accounted for a larger share of the market.
However, the sole source segment is expected to register a higher CAGR during the forecast period.
Based on form, the enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment is expected to hold the largest share of the market in 2021 and register the highest CAGR during the forecast period.
Based on product, the enteral medical nutrition market is segmented into standard protein diets, high protein diets, fruit juice-based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2021.
However, the fruit juice-based oral nutritional supplement segment is expected to register the highest CAGR during the forecast period.
Based on distribution channel, the enteral medical nutrition market is segmented into hospital pharmacies, retail outlets, and other pharmacies.The hospital pharmacy segment accounted for the largest share of the market in 2021.
However, the retail store segment is expected to register the highest CAGR during the forecast period.
Based on age, the enteral medical nutrition market is divided into children (up to 18 years old) and adults (18 years old and above). The adult (18+) segment will have a large share in 2021.
However, the children (up to 18 years old) segment is expected to register a higher CAGR during the forecast period.
The World Health Organization (WHO), the American Society for Parenteral and Enteral Nutrition, the American Society of Clinical Oncology, and the Centers for Disease Control and Prevention refer to some of the key primary and secondary Source of information.
Read the full report: https://www.reportlinker.com/p06321036/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can instantly get all the market research you need in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Comments
Post a Comment